Keywords
Isocitrate dehydrogenaseIDH1IDH2BiologyMutantCancer researchEpigeneticsHistoneEnzymeBiochemistryGene
Affiliated Institutions
Related Publications
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Purpose Several prognostic scoring systems have been proposed for chronic myelomonocytic leukemia (CMML), a disease in which some gene mutations—including ASXL1—have been associ...
Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing
Abstract Estimating the malignancy level of tumors is key to management, and has been part of oncology practice for the past ∼100 years. A central aspect of assessing malignancy...
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
We examined the gene expression profiles of two independent cohorts of patients with acute myeloid leukemia [n=247 and n=214 (younger than or equal to 60 years)] to study the ap...
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of <i>EGFR</i>
Abstract Background Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense mutations in the epiderma...
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
Disease overview : Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of newly diagnosed ca...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 34
- Issue
- 2
- Pages
- 186-195
- Citations
- 303
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
303
OpenAlex
Cite This
Matthew S. Waitkus,
Bill H. Diplas,
Hai Yan
(2018).
Biological Role and Therapeutic Potential of IDH Mutations in Cancer.
Cancer Cell
, 34
(2)
, 186-195.
https://doi.org/10.1016/j.ccell.2018.04.011
Identifiers
- DOI
- 10.1016/j.ccell.2018.04.011